The Game Awards 2022 are a wrap, and Elden Ring took home the biggest award of the night: Game of the Year. God of War Ragnarok also did pretty well for itself, taking home a handful of awards.

After playing Horses, I found it fascinating, but it didn't take its juxtaposition of mundane chores and extreme violence far enough. When you purchase through links on our site, we may earn an ...

Covering the video games industry since 2017, with experience in news, articles, lists, and reviews (and I blame The Legend of Zelda: Majora's Mask for that). If you are a fan of RPGs and want a third ...

Forbes contributors publish independent expert analyses and insights. News and opinion about video games, television, movies and the internet. We are just hours away from The Game Awards, which honor ...

The Game Awards returned in 2025 for a big show celebrating the best games of the past year and an exciting look at the future. You can check out all The Game Awards winners right here, and you can ...

Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...

Wondering if Recursion Pharmaceuticals at around $4.83 is a beaten down bargain or a value trap? This breakdown walks through what the current market price is really implying. The stock has bounced ...

Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...

Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Monday after the pharmaceutical company reported positive data from an ongoing trial. What To Know: Recursion ...

In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...